Antikor News Items

1. Antikor attending the inaugural Novel Format Conjugates Summit April 2022
   
2. Antikor will present a poster called ‘Gastric Cancer Antibody FDCs’ at AACR April 2022
   
3. Antikor presenting a poster at the World ADC London Conference March/April 2022
   
4. Antikor is presenting the Stream Keynote Lecture ‘Advances in ADC Engineering’ at Biologics UK 2022
   
5. Antikor presenting at the 6th Annual Next-Generation Immuno-oncology Conference, March 2022
   
6. Antikor Biopharma and Essex Bio-Technology Forge Strategic Alliance in FDC for Cancer Treatment
   
7. Antikor takes aim at solid tumours with antibody-fragment conjugates
   
8. Superior Toxicology Data from Antikor’s FDC Platform
   
9. February 2017: Antikor is seeking to recruit top protein scientists
   
10. Antikor awarded an Innovate-UK Early Stage award December 2016
    
11. Breakthrough Achieved by Antikor Biopharma with Fragment-Drug Conjugates!
    
12. Antikor invited to present at BioTrinity, April 2016
    
13. Antikor CSO/COO attending the 6th World ADC Summit, Berlin, 8-10th February 2016
    
14. Antikor attending Biotech & Money, London 2-3 February 2016
    
15. Antikor attending Genesis 2015, London, 10th December
    
16. Antikor invited to ‘Accessing US Capital In Life Sciences’, 1st December 2015
    
17. Antikor selected to present at OBN CEO & Investor Forum, London, 24th November 2015
    
18. Antikor invited to the World ADC Mastermind meeting in Cambridge, UK, 2nd September 2015
    
19. Antikor invited to Amgen Partner Symposium Programme, 21 July 2015
    
20. Antikor team publish review article on Emerging formats for next-generation antibody drug conjugates
    
21. Antikor moves into new premises at Stevenage BioScience Catalyst